Hospital or health organisation · founded 1981
Moffitt Cancer Center
Tampa, United States · moffitt.org
- Citations, last 5 years
- 134.7k
- Works, last 5 years
- 13.7k
- h-index
- 815
- Scientists listed
- 950
- Grants since 2016
- 1 073
Grants received
2020–2023 · fellowship · F31
The importance of CD4+ tumor-infiltrating lymphocytes (TIL) in adoptive cell transfer
Maclean Hall · Moffitt Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma
John L. Cleveland · Moffitt Cancer Center · funded by National Institutes of Health
2020–2022 · research · R21
Modulating Glioblastoma Stem Cell Clonal Evolution Towards Therapeutic Responsiveness
Arnold Etame · Moffitt Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
Daniel Abate-Daga · Moffitt Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Transcriptional and Epigenetic Adaptation as Novel Therapeutic Vulnerabilities for Mantle Cell Lymphoma
Derek Ronald Duckett · Moffitt Cancer Center · funded by National Institutes of Health
2020–2026 · research · R01
Imaging Acidosis and Immune Therapy in PDAC
Arig A Ibrahim Hashim · Moffitt Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
Daniel Abate-Daga · Moffitt Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Identifying and Reducing Disparities in Patient-Reported Outcomes Among African American Prostate Cancer Survivors
Brian D Gonzalez · Moffitt Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Functional characterization of prostate cancer risk loci by high throughput sequencing
Liang Wang · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · training · T32
Cancer Research Workforce Development in FAIR Artificial Intelligence and Machine Learning
William Douglas Cress · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of dendritic cell function and tumor immunity by TIM-3
Brian Ruffell · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Functional reprogramming of tumor-MDSC through antibody-based therapies targeting Notch ligands
Paulo Cesar Rodriguez · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Optimal Decision Making in Radiotherapy Using Panomics Analytics
Issam M. El Naqa · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R37
Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology
Daniel Jeong · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · training · T32
Behavioral Oncology Education & Career Development
Vani N Simmons · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · training · T32
Behavioral Oncology Education & Career Development
Thomas H Brandon · Moffitt Cancer Center · funded by National Institutes of Health
2019–2026 · research · R37
Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology
Daniel Jeong · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Local and systemic control of multiple myeloma colonization and growth by MMP-13
Conor C Lynch · Moffitt Cancer Center · funded by National Institutes of Health
2019–2021 · research · R03
Motivating a Spectrum of Cancer Patients to Quit Smoking: Intervention Development and Feasibility
Ursula Martinez Pradeda · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Functional reprogramming of tumor-MDSC through antibody-based therapies targeting Notch ligands
Paulo Cesar Rodriguez · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Functional reprogramming of tumor-MDSC through antibody-based therapies targeting Notch ligands
Paulo Cesar Rodriguez · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · career development · K08
Finding Synergy with Radiation Therapy and Immunotherapy for Patients with Lung Cancer
Bradford A. Perez · Moffitt Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV
Damon J. Vidrine · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · training · T32
Integrated Program in Cancer and Data Science
William Douglas Cress · Moffitt Cancer Center · funded by National Institutes of Health
2019–2022 · research · R34
Utilizing Augmented Reality as an Adjunct for Smoking Cessation: Development and Initial Validation
Thomas H Brandon · Moffitt Cancer Center · funded by National Institutes of Health
2019–2020 · research · R03
Motivating a Spectrum of Cancer Patients to Quit Smoking: Intervention Development and Feasibility
Ursula Martinez Pradeda · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · career development · K08
Finding Synergy with Radiation Therapy and Immunotherapy for Patients with Lung Cancer
Bradford A. Perez · Moffitt Cancer Center · funded by National Institutes of Health
2019–2023 · career development · K08
Finding Synergy with Radiation Therapy and Immunotherapy for Patients with Lung Cancer
Bradford A. Perez · Moffitt Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Randomized Trial of Automated Video-Assisted Smoking Treatment for People Living with HIV
Damon J. Vidrine · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation
Eric Kirk Lau · Moffitt Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Phase II Clinical trial of GTC in Men on Active Surveillance
Nagi B. Kumar · Moffitt Cancer Center · funded by National Institutes of Health
2019–2023 · research · R01
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · career development · K08
Finding Synergy with Radiation Therapy and Immunotherapy for Patients with Lung Cancer
Bradford A. Perez · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Functional reprogramming of tumor-MDSC through antibody-based therapies targeting Notch ligands
Paulo Cesar Rodriguez · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · training · T32
Behavioral Oncology Education & Career Development
Thomas H Brandon · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers
Damon J. Vidrine · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Local and systemic control of multiple myeloma colonization and growth by MMP-13
Conor C Lynch · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Local and systemic control of multiple myeloma colonization and growth by MMP-13
Conor C Lynch · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targetable epigenetic mechanism driving Cutaneous T cell Lymphoma
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers
Damon J. Vidrine · Moffitt Cancer Center · funded by National Institutes of Health